8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Oct 11, 2024 · 1y ago · Accession 0001437749-24-031133
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K
- Filing date
- Oct 11, 2024
- Report date
- Oct 7, 2024
- Document
- nrxp20241011_8k.htm
- Size
- 268 KB